Intelligent Bio jumps on higher Q3 revenue, expansion plans

Intelligent Bio Solutions

12/05/2023 12:46

** Shares of diagnostic tests developer Intelligent Bio
Solutions Inc  INBS.O  up 9.8% at $3.24 premarket
    ** Company posts a near three-fold jump in Q3 combined
revenue and government support income to $0.5 mln
    ** Jump in Q3 revenue reflects acquisition of Intelligent
Fingerprinting Ltd in Q2 and introduction of commercial products
- company
    ** INBS expects to launch its Intelligent Fingerprinting
Drug Screening System in Australia, New Zealand and APAC region
in the coming fiscal year
    ** Also expects to "investigate entry" into non-FDA
regulated markets in the U.S. 
    ** Up to last close, INBS down ~26.2% YTD

 (Reporting by Anandita Mehrotra in Bengaluru)
 ((Anandita.Mehrotra@thomsonreuters.com))